Michael Klichinsky
2023
In 2023, Michael Klichinsky earned a total compensation of $1.6M as Current Chief Scientific Officer at Eleven Biotherapeutics.
Compensation breakdown
| Bonus | $164,640 |
|---|---|
| Option Awards | $1,077,948 |
| Salary | $345,625 |
| Other | $15,164 |
| Total | $1,603,377 |
Klichinsky received $1.1M in option awards, accounting for 67% of the total pay in 2023.
Klichinsky also received $164.6K in bonus, $345.6K in salary and $15.2K in other compensation.
Rankings
In 2023, Michael Klichinsky's compensation ranked 736th out of 3,006 executives tracked by ExecPay. In other words, Klichinsky earned more than 75.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 736 out of 3,006 | 76th |
Division Manufacturing | 421 out of 1,650 | 75th |
Major group Chemicals And Allied Products | 285 out of 918 | 69th |
Industry group Drugs | 279 out of 881 | 68th |
Industry Pharmaceutical Preparations | 183 out of 637 | 71st |
Source: SEC filing on April 29, 2024.
Klichinsky's colleagues
We found five more compensation records of executives who worked with Michael Klichinsky at Eleven Biotherapeutics in 2023.
2023
Steven Kelly
Eleven Biotherapeutics
Chief Executive Officer
2023
Thomas Cannell
Eleven Biotherapeutics
Chief Executive Officer
2023
Richard Morris
Eleven Biotherapeutics
Chief Financial Officer
2023
Monica Forbes
Eleven Biotherapeutics
Chief Financial Officer
2023
Mark Sullivan
Eleven Biotherapeutics